Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

  • Esquirol, Albert|||0000-0002-6062-5980
  • Pascual, Maria Jesús|||0000-0002-9859-0816
  • Kwon, Mi|||0000-0002-3855-7774
  • Pérez, Ariadna
  • Parody Porras, Rocío
  • Ferrá, Christelle|||0000-0003-4571-5125
  • García Cadenas, Irene|||0000-0002-2994-9055
  • Herruzo, Beatriz
  • Dorado-Herrero, Nieves
  • Hernani, Rafael|||0000-0003-1043-8076
  • Sánchez Ortega, Isabel
  • Torrent Catarineu, Anna|||0000-0002-3727-5716
  • Sierra, Jorge|||0000-0002-7966-0356
  • Martino Bofarull, Rodrigo|||0000-0001-5143-4042
Severe infections and their attributable mortality are major complications in recipients of allogeneic hematopoietic stem cell transplantation (alloSCT). We herein report 236 adult patients who received haploSCT with PTCy. The median follow-up for survivors was 37 months. The overall incidence of bloodstream infections by gram-positive and gram-negative bacteria at 37 months was 51% and 46%, respectively. The incidence of cytomegalovirus infection was 69%, while Epstein Barr virus infections occurred in 10% of patients and hemorrhagic cystitis in 35% of cases. Invasive fungal infections occurred in 11% at 17 months. The 3-year incidence of infection-related mortality was 19%. The median interval from transplant to IRM was 3 months (range 1-30), 53% of IRM occurred.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Combining Three Different Pretransplantation Scores Improves Predictive Value in Patients after Haploidentical Stem Cell Transplantation with Thiotepa, Busulfan, and Fludarabine Conditioning and Post-Transplantation Cyclophosphamide

  • Esquirol, Albert|||0000-0002-6062-5980
  • Pascual, Maria Jesus
  • García Cadenas, Irene|||0000-0002-2994-9055
  • Herruzo, Beatriz
  • Ferrá, Christelle|||0000-0003-4571-5125
  • Pérez, Ariadna
  • Torio, Alberto
  • Torrent Catarineu, Anna|||0000-0002-3727-5716
  • Cuesta, Marian
  • Martino Bofarull, Rodrigo|||0000-0001-5143-4042
  • Sierra, Jorge|||0000-0002-7966-0356
One hundred and sixty-one patients underwent haploidentical stem cell transplantation (haploSCT) with thiotepa, busulfan, and fludarabine conditioning followed by post-transplantation cyclophosphamide (PTCy) (on days +3 and +4) and tacrolimus as graft-versus-host disease prophylaxis. Forty-two percent of patients had a high or very high revised Disease Risk Index (rDRI), 55% had an European Society for Blood and Marrow Transplantation risk score (EBMT-RS) ≥4, and 36% had an age-adjusted Hematopoietic Cell Transplant Comorbidity Index (HCT-CI-age) score ≥3. Each of these was considered an unfavorable score. Using the pretransplantation unfavorable scores that had an independent impact on each transplantation outcome studied in multivariate analysis allowed for better stratification of patient outcomes. Thus, the 3-year overall survival (OS) in patients with 0, 1, 2, and 3 unfavorable scores was 86%, 56%, 36%, and 24%, respectively. Nonrelapse mortality (NRM) was negatively impacted by the EBMT-RS and the HCT-CI-age score (3-year NRM in patients with 0, 1, and 2 unfavorable scores was 12%, 33%, and 43%, respectively), whereas the EBMT-RS and the rDRI had an impact on the 3-year relapse incidence (8%, 18%, and 41% in patients with 0, 1, and 2 unfavorable scores, respectively). In conclusion, our study shows that combining 2 or 3 of these well-defined pretransplantation scores improves the ability to predict transplantation outcomes in the setting of haploSCT with PTCy.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Post-Thaw Viable CD45+ Cells and Clonogenic Efficiency are Associated with Better Engraftment and Outcomes after Single Cord Blood Transplantation in Adult Patients with Malignant Diseases

  • Castillo Flores, Nerea
  • García Cadenas, Irene|||0000-0002-2994-9055
  • Barba, Pere|||0000-0001-7076-7969
  • Martino Bofarull, Rodrigo|||0000-0001-5143-4042
  • Azqueta, Carmen
  • Ferrá, Christelle|||0000-0003-4571-5125
  • Canals, Carme
  • Sierra, Jorge|||0000-0002-7966-0356
  • Valcárcel, David|||0000-0002-8747-078X
  • Querol, Sergi|||0000-0002-1105-8633
The quantity of cells is widely accepted as the main factor influencing the outcome after umbilical cord blood transplantation (UCBT) however, the quality of the cord blood units (CBUs) has been less studied. In order to determine the impact of qualitative variables in UCBT outcomes, we conducted a multicenter retrospective study in adult patients with hematological malignancies who underwent single UCBT after a common myeloablative conditioning regimen. One hundred and ten patients from 3 institutions [median age, 35 years (range 18-55)] were included. Quantitative (TNC and total CD34+cells) and qualitative variables [viable CD45+ (vCD45+), vCD34+ and clonogenic efficiency [(CLONE), quotient of post-thaw colony-forming units (CFU)] and pre-freeze CD34+ cells predicted engraftment in univariate analysis however, only 2 qualitative variables remained significant in the multivariate analysis. Infusion of more than 2 × 10 post-thaw vCD45+ cells per kilogram was significantly associated with faster neutrophil (P =.01), platelet engraftment (P =.01), higher disease-free (P =.01) and overall survival (0.02). In addition, CLONE ≥ 20% predicted a faster neutrophil (P =.005), platelet engraftment (P =.01) and contributed to decrease the non-relapse mortality (P =.02). Our study suggests that the vCD45+ cells dose and CLONE are powerful surrogate markers of graft quality and can potentially help on CBUs selection if tested with representative reference samples.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Few and nonsevere adverse infusion events using an automated method for diluting and washing before unrelated single cord blood transplantation

  • Castillo Flores, Nerea
  • García Cadenas, Irene|||0000-0002-2994-9055
  • García, Olga
  • Barba, Pere|||0000-0001-7076-7969
  • Diaz-Heredia, Cristina
  • Martino Bofarull, Rodrigo|||0000-0001-5143-4042
  • Azqueta, Carmen
  • Ferrá, Christelle|||0000-0003-4571-5125
  • Canals, Carme
  • Elorza Álvarez, Izaskun|||0000-0003-4781-5605
  • Olivé, Teresa
  • Badell Serra, Isabel|||0000-0001-6546-2175
  • Sierra, Jorge|||0000-0002-7966-0356
  • Duarte, Rafael|||0000-0002-5240-9815
  • Valcárcel, David|||0000-0002-8747-078X
  • Querol, Sergi|||0000-0002-1105-8633
Graft dilution and DMSO washing before cord blood (CB) administration using an automated system may offer low incidence of adverse infusion events (AIE), ensuring reproducible cell yields. Hence, we analyzed the incidences and significance of immediate AIE, cellular yield, and engraftment after single CB infusion. One hundred and fifty-seven patients (median age, 20 years; range, 1 to 60) received a single CB unit for treatment of hematologic and nonhematologic malignancies with myeloablative conditioning after graft dilution and washing. The median total nucleated cell (TNC) doses was 3.4× 10/kg (range, 2 to 26) and the median post-thaw recovery was 84% (range, 45 to 178). The cumulative incidence of neutrophil engraftment at 50 days was 84% (95% confidence interval [CI], 83 to 93). A total of 118 immediate AIE were observed in fifty-two (33%) patients. All reported AIE were transient, graded from 1 to 2 by Common Terminology Adverse Events version 4. The most frequent toxicity was cardiovascular but without any life-threatening reaction. Infused TNC, recipient's weight, and rate of infusion per kilogram were risk factors associated with cardiovascular AIE in multivariate analysis (odds ratio [OR], 1.2 (95% CI, 1.1 to 1.4); P <.001; OR,.94 (95% CI,.9 to.97); P <.001; and OR, 1.5 (95% CI, 1.2 to 1.8); P <.001; respectively). In summary, use of an automated method for graft washing before CB administration showed low incidence of AIE without compromising cell yields and engraftment. Infused TNC dose, recipient's weight, and rate of infusion per kilogram were risk factors associated with infusion reactions.